Amalgamated Bank’s iRadimed IRMD Stock Holding History

Amalgamated Bank’s Portfolio IRMD Stock Details IRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-256	Closed	-$25K	–	2218
2025 Q4	$25K	Sell	256 -22	-8%	-$1.89K	﹤0.01%	2023
2025 Q3	$20K	Hold	278	–	–	﹤0.01%	2127
2025 Q2	$17K	Hold	278	–	–	﹤0.01%	2182
2025 Q1	$15K	Buy	278 +57	+26%	+$3.2K	﹤0.01%	2180
2024 Q4	$12K	Hold	221	–	–	﹤0.01%	2349
2024 Q3	$11K	Hold	221	–	–	﹤0.01%	2400
2024 Q2	$10K	Hold	221	–	–	﹤0.01%	2445
2024 Q1	$10K	Sell	221 -789	-78%	-$34.9K	﹤0.01%	2444
2023 Q4	$48K	Sell	1,010 -66	-6%	-$2.77K	﹤0.01%	2271
2023 Q3	$48K	Hold	1,076	–	–	﹤0.01%	2274
2023 Q2	$51K	Buy	1,076 +116	+12%	+$5.23K	﹤0.01%	2311
2023 Q1	$38K	Sell	960 -150	-14%	-$5.45K	﹤0.01%	2413
2022 Q4	$31K	Hold	1,110	–	–	﹤0.01%	2614
2022 Q3	$33K	Buy	1,110 +17	+2%	+$592	﹤0.01%	2630
2022 Q2	$37K	Buy	1,093 +57	+6%	+$2.04K	﹤0.01%	2622
2022 Q1	$46K	Buy	+1,036	New	+$47.9K	﹤0.01%	2522

Other funds holding IRMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

NTCM

Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Amalgamated Bank's IRMD Position: Q1 2026 in Review

Amalgamated Bank sold out of iRadimed (IRMD) in Q1 2026, closing a stake of 256 shares — an estimated $25K sold.

Amalgamated Bank first reported a position in IRMD in Q1 2022 and held it in 16 quarters. The position peaked at $51K in Q2 2023. 228 funds tracked by Wall St. Rank hold IRMD as of Q1 2026.

Amalgamated Bank reported no remaining iRadimed position as of Q1 2026 after selling out during the quarter.
Amalgamated Bank sold 256 iRadimed shares in Q1 2026, an estimated $25K.
Amalgamated Bank first reported a position in iRadimed in Q1 2022 and held it in 16 quarters.
Amalgamated Bank's iRadimed position peaked at $51K in Q2 2023.
228 funds tracked by Wall St. Rank held iRadimed as of Q1 2026.

Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.